Sividon Diagnostics' Grant

Sividon Diagnostics raised a round of funding on May 02, 2015. Investors include Horizon 2020.

Sividon Diagnostics develops breast cancer prognostic tests. Sividon's core EndoPredict product is a kit-based RNA expression test designed to assess the aggressiveness of breast cancer on a molecular…

Articles about Sividon Diagnostics' Grant: